Ishita Drugs & Industries Ltd.
Snapshot View

45.00 +0.70 ▲1.6%

27 June 2022, 04:01:00 PM
Volume: 1,497

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ishitadrugs.com
Market Cap 13.46 Cr.
Enterprise Value(EV) 8.77 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 2.69 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 16.74 Trailing Twelve Months Ending 2022-03
Industry PE 29.84 Trailing Twelve Months Ending 2022-03
Book Value / Share 28.74 Trailing Twelve Months Ending 2022-03
Price to Book Value 1.57 Calculated using Price: 45.00
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 0.30 Cr. 2,990,300 Shares
FaceValue 10
Company Profile
Ishita drugs & industries limited (IDIL), an Ishita Group company was incorporated in 1992, the company is listed on the local stock exchanges in India and has earned a reputation as a 'high quality manufacturer' in a very short time.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+1.58%
1 Week
+4.41%
1 Month
-10.63%
3 Month
+7.27%
6 Month
+1.47%
1 Year
+54.11%
2 Year
+150.28%
5 Year
+122.77%
10 Year
+251.56%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 8.60 3.95 4.12 2.47 3.19 4.17 5.64 8.18 11.25
Return on Capital Employed (%) 12.85 6.27 5.98 4.02 4.79 7.26 8.17 10.79 14.39
Return on Assets (%) 6.23 2.80 3.26 1.81 2.37 3.46 4.54 6.12 8.82

Balance Sheet View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 5 5 5 6 6 6 6 7 8 9
Non Curr. Liab. 0 0 0 0 0 0 0 0 0 0
Curr. Liab. 3 1 1 3 1 1 2 3 1 3
Minority Int.
Equity & Liab. 8 7 7 8 7 7 8 10 9 11
Non Curr. Assets 1 2 1 1 1 1 2 1 1 1
Curr. Assets 7 5 6 7 6 6 7 8 8 10
Misc. Exp. not W/O
Total Assets 8 7 7 8 7 7 8 10 9 11

Profit Loss View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 11 7 7 7 6 7 9 15 14 14
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 11 7 7 7 6 7 9 15 14 14
Total Expenditure -10 -6 -7 -6 -6 -6 -9 -14 -13 -13
PBIDT 1 0 0 0 0 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 1 1 1
Adjusted EPS 1 1 1 0 1 1 1 2 3 3

Cash Flow View Details

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 1 0 1 0 0 1 1 1 1 -1
Cash Fr. Inv. 0 0 0 0 0 -1 -1 -1 -1 2
Cash Fr. Finan. 0 0 0 0 1 -1 0 0 0 0
Net Change 0 0 0 0 1 -1 0 0 0 2
Cash & Cash Eqvt 1 1 1 1 2 1 1 1 1 3

Shareholding Pattern View Details

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 47.78 47.80 47.87 47.87 47.87 47.87 47.87 48.37 49.31
Public 52.22 52.20 52.13 52.13 52.13 52.13 52.13 51.63 50.69
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Thu, 09 Jun 2022
Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
This is to inform you that Related Party Transactions disclosure as required under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 is not applicable to our company.
Mon, 06 Jun 2022
Revised Certificate File Under Reg.40 (9) & Reg.40 (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Year Ended March 31 2022
With reference to your email dated 1st June 2022 we are enclosing herewith the revised certificate under Reg.40 (9) & Reg.40 (10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 issued by M/s. Meenu Maheshwari & Associates Practicing Company Secretaries for the year ended 31st March 2022.
Mon, 30 May 2022
Outcome Of Board Meeting Held On 30Th May 2022
Approved the Audited Financial Results of the Company for the quarter and year ended 31st March 2022.

Technical Scans View Details

Mon, 27 Jun 2022
High Delivery Percentage High Delivery Percentage
Opening at Low Opening at Low
Making Lower Lows for 3 days Making Lower Lows for 3 days
High Decrease 1 Month High Decrease 1 Month
High Increase 1 Year High Increase 1 Year

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 200,572.41 835.95 +1.4%
Divi's Laboratories Ltd. 97,518.56 3,679.05 0.0%
Cipla Ltd. 75,086.75 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. 71,855.08 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. 54,559.09 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. 48,438.53 2,858.25 -0.6%
Gland Pharma Ltd. 43,775.42 2,658.60 +0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 61.29 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 32.99 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 29.83 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.92 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 51.70 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 62.24 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 36.13 2,658.60 +0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.18 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8.33 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 3.60 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.74 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.68 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8.12 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 6.12 2,658.60 +0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 0.10 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 19,159.59 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,658.60 +0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 2,401.30 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,658.60 +0.6%

FAQ's On Ishita Drugs & Industries Ltd.

Can I Buy Ishita Drugs & Inds. Shares now?

What is the Share Price of Ishita Drugs & Inds.?

What is the Relative Strength Index (RSI) Value of Ishita Drugs & Inds.?

What is the Market Capital (MCAP) of Ishita Drugs & Inds.?

What are the key metrics to analyse Ishita Drugs & Inds.?

What is the Price Performance of Ishita Drugs & Inds.?